Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema - A Pilot Study (CSP-12123)

NCT06655428 is registered in ClinicalTrials.gov with Morair Medtech, LLC as lead sponsor.

NCT NCT06655428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06655428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema - A Pilot Study (CSP-12123)
Lead sponsor
Morair Medtech, LLC
Phase
Not applicable
Overall status
Recruiting
Start date
January 10, 2025
Completion date
May 31, 2026
Enrollment
30 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

copd, copd (chronic obstructive pulmonary disease), emphysema, emphysema or copd, emphysema, pulmonary